[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100570709":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":20,"locations":29,"responsibleParty":50,"collaborators":19,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":19,"studyType":66,"phases":67,"briefSummary":57,"conditions":69,"keywords":19,"overallStatus":32,"whyStopped":19,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Phoenix Children's Hospital","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"girls facing possible infertility","Newly diagnosed female or relapsed malignancy who is 1-25 years of age with proposed treatment regimen containing at least ONE (1) of the following:\n\nwhole abdomen or pelvic irradiation total body irradiation\n\nProposed treatment regimen to include any of the following:\n\ncyclophosphamide equivalent dose (CED, see Green et al 2014) ≥7.5 g\u002Fm2 any treatment regimen containing procarbazine bone marrow transplant conditioning regimen containing alkylator OR health condition or malignancy that requires removal of one or both ovaries",[12],"Procedure: Ovarian tissue removal will be performed laparoscopically",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"PROCEDURE","Ovarian tissue removal will be performed laparoscopically","under general anesthesia concomitantly with another scheduled procedure if possible. Following removal, ovarian tissue will be shipped to University of Pittsburg Medical Center, Magee-Womens Research Institute for processing. Freezing and storing techniques will be in accordance with FDA regulations for reproductive tissues, guidelines of the American Association of Tissues Banks and any other applicable federal, state and local regulations. The tissue will be carefully separated dividing the cortex from the medulla. The cortex will then be cryopreserved for long term storage. The medulla will be shipped overnight back to the PCH Department of Pathology for histological evaluation. If pathology finds evidence of cancer in the ovarian tissue provided, they may request that all of the patient's tissue be returned to pathology for a more detailed examination, which may eliminate the tissue available for the patient's future use.",[9],null,[21,26],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Alexandra Walsh, MD","CONTACT","602-933-4483","awalsh@phoenixchildrens.com",{"name":27,"role":23,"phone":24,"phoneExt":19,"email":28},"Briana Fodor","bfodor@phoenixchildrens.com",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Phoenix Childrens","RECRUITING","Phoenix","Arizona","85016","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-112.07404,33.44838,{"lat":42,"lon":41},[45,47],{"name":22,"role":23,"phone":46,"phoneExt":19,"email":25},"6029330916",{"name":48,"role":23,"phone":49,"phoneExt":19,"email":28},"Briana Fodor, BS","6029332548",{"type":51,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100570709","ovarian-tissue-cryopreservation-100570709",false,"NCT06710769","Ovarian Tissue Cryopreservation","Ovarian Tissue Freezing For Fertility Preservation In Girls Facing A Fertility Threatening Medical Diagnosis Or Treatment Regimen","OTC","Inclusion Criteria:\n\n* Newly diagnosed or relapsed malignancy with proposed treatment regimen containing at least ONE (1) of the following:\n\nwhole abdomen or pelvic irradiation\n\ntotal body irradiation\n\nProposed treatment regimen to include any of the following:\n\ncyclophosphamide equivalent dose (CED, see Green et al 2014) ≥7.5 g\u002Fm2\n\nany treatment regimen containing procarbazine\n\nbone marrow transplant conditioning regimen containing alkylators\n\nOR health condition or malignancy that requires removal of one or both ovaries. Health status adequate to undergo elective laparoscopic surgery (as per anesthesiologist assessment)\n\nExclusion Criteria:\n\n* Pregnancy or a patient who is currently breastfeeding\n\nPatients who are eligible for and agree to oocyte preservation\n\nAnyone deemed high risk for complications from the surgery and\u002For anesthesia.\n\nAnyone unable to provide consent due to psychiatric conditions or cognitive delay (in parent\u002Fguardian for patients \\\u003C18 years, and patient \\>18 years)","FEMALE","1 Year","25 Years",{"count":64,"type":65},40,"ESTIMATED","INTERVENTIONAL",[68],"NA",[70],"Infertility, Female","2026-01-22",{"date":73,"type":74},"2026-01-23","ACTUAL",{"date":76,"type":74},"2020-07-30",{"date":78,"type":65},"2031-07",{"name":5,"class":6},1]